Literature DB >> 29466814

[DGP Interstitial Lung Disease Patient Questionnaire].

M Kreuter1, U Ochmann2, D Koschel3, J Behr4, F Bonella5, M Claussen6, U Costabel5, S Jungmann7, M Kolb8, D Nowak2, F Petermann9, M Pfeiffer10, M Polke1, A Prasse11, J Schreiber12, J Wälscher1, H Wirtz13, D Kirsten14.   

Abstract

BACKGROUND: Interstitial lung diseases (ILD) encompass different heterogeneous, mainly chronic diseases of the pulmonary interstitium and/or alveoli with known and unknown reasons. The diagnostic of ILD is challenging and should be performed interdisciplinary. The medical history is of major importance and therefore, in German-speaking countries the Frankfurter Bogen (published in 1985) was utilised to scrutinise the medical history of the patient. This by now more than 30-years-old questionnaire requires a revision with regard to content and language.
METHOD: Under the auspices of the clinical section of the DGP the new Interstitial Lung Disease Patient Questionnaire was developed in collaboration amongst pulmonologist, occupational medicine physicians and psychologists and supported by patient support groups. The questionnaire was finally optimised linguistically with the help of patients.
RESULTS: The newly developed patient questionnaire for interstitial and rare lung diseases encompasses different domains: initial and current symptoms, medical history questions including prior drug treatments, previous pulmonary and extrapulmonary diseases, potential exposition at home, work and leisure time as well as family history and travelling.
CONCLUSION: The newly developed questionnaire can facilitate the diagnosis in patients with suspicion on interstitial lung disease in clinical routine. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 29466814     DOI: 10.1055/s-0044-100207

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  6 in total

Review 1.  [Rheumathism and pneumology].

Authors:  A Jakubczyc; C Neurohr
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

2.  The Diagnosis and Treatment of Pulmonary Fibrosis.

Authors:  Michael Kreuter; Ulf Müller Ladner; Ulrich Costabel; Danny Jonigk; Claus Peter Heussel
Journal:  Dtsch Arztebl Int       Date:  2021-03-05       Impact factor: 5.594

3.  Bronchoscopic Probe-Based Confocal Laser Endomicroscopy to Diagnose Diffuse Parenchymal Lung Diseases.

Authors:  Edith Silbernagel; Elvira Stacher-Priehse; Julien Dinkel; Herbert Stepp; Wolfgang Gesierich; Michael Lindner; Juergen Behr; Frank Reichenberger
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

4.  Comorbidities in unclassifiable interstitial lung disease.

Authors:  Thomas Skovhus Prior; Charlotte Hyldgaard; Sebastiano Emanuele Torrisi; Elisabeth Bendstrup; Michael Kreuter; Sissel Kronborg-White; Claudia Ganter
Journal:  Respir Res       Date:  2022-03-16

Review 5.  [Occupational diseases of the airways and the lungs].

Authors:  Dennis Nowak; Uta Ochmann; Ullrich G Mueller-Lisse
Journal:  Internist (Berl)       Date:  2021-08-13       Impact factor: 0.743

6.  A New Tool to Assess Quality of Life in Patients with Idiopathic Pulmonary Fibrosis or Non-specific Interstitial Pneumonia.

Authors:  Detlef Kirsten; Ulrike de Vries; Ulrich Costabel; Dirk Koschel; Francesco Bonella; Andreas Günther; Jürgen Behr; Martin Claussen; Stefan Schwarz; Antje Prasse; Michael Kreuter
Journal:  Pneumologie       Date:  2021-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.